UPDATE: Sunesis Reports Schedule C Had Most Favorably Safety/Efficacy Balance
November 24, 2014 at 07:24 AM EST
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the publication of results from the Company's REVEAL-1 (Response ...